MKI67 and neoplasm: Moreover, Fukami reported that Ki-67, a marker of cell proliferation, was increased to 80% in tumor cells after the second stage of ALPPS, and this increase was higher than that identified in the first stage in patients with colon cancers and synchronous multiple liver metastases [33].